Caribou raises $304M in one of gene editing's most lucrative IPOs

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 24, 2021 at 6:42 PM.

  1. #1 cafead, Jul 24, 2021 at 6:42 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Caribou Biosciences, one of the first biotech companies formed to turn CRISPR gene editing technology into medicines for humans, raised just over $300 million in an initial public offering priced Thursday, making the leap to public markets roughly 10 years after its founding.

    article source
     
    Quote

Reply to Thread